Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review.
Mult Scler Relat Disord
; 63: 103926, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35661568
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuromyelitis Optica
Type of study:
Guideline
/
Prognostic_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2022
Document type:
Article
Country of publication:
Netherlands